Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Dear Doctor Letter (Rote-Hand-Brief) on medicinal products containing mycophenolate mofetil (MMF)/mycophenolic acid (MPA): updated recommendations for contraception
2018.02.07
Active substance: mycophenolate
As mycophenolate mofetil (MMF) and mycophenolic acid (MPA) are known to be genotoxic, it is recommended that the male patient or his female partner use reliable contraception during treatment and for at least 90 days after the end of the treatment.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN